Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of PF-08049820 With and Without Rabeprazole in Healthy Chinese Adults
NCT07284173Phase 1Completed
- Sponsor
- Pfizer
- Start
- Nov 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of PF-08049820 (2 arms), sponsored by Pfizer. Primary endpoints: Maximum Observed Plasma Concentration and Area under the plasma concentration. Started Nov 2025; status: completed.
02
Drugs
PF-08049820
Beyond the preview
Go deeper on NCT07284173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07284173.